Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Clinical trial NCT03079687 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT03079687
- Sponsor
- AstraZeneca
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.